======= NPY2R ======= == Gene Information == * **Official Symbol**: NPY2R * **Official Name**: neuropeptide Y receptor Y2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4887|4887]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49146|P49146]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NPY2R&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NPY2R|Open PubMed]] * **OMIM**: [[https://omim.org/entry/162642|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PYY > NPY > PYY (3-36) > NPY (2-36) > [Ile-31, Gln-34] PP > [Leu- 31, Pro-34] NPY > PP, [Pro-34] PYY and NPY free acid. |7tm 1| |7TM GPCR Srsx| |peptide YY receptor activity| |positive regulation of circadian sleep/wake cycle, non-REM sleep| |positive regulation of circadian sleep/wake cycle, sleep| |positive regulation of dopamine secretion| |regulation of circadian sleep/wake cycle, non-REM sleep| |negative regulation of synaptic transmission, glutamatergic| |negative regulation of feeding behavior| |neuropeptide Y receptor activity| |negative regulation of excitatory postsynaptic potential| |positive regulation of catecholamine secretion| |cardiac left ventricle morphogenesis| |positive regulation of circadian rhythm| |negative regulation of behavior| |regulation of circadian sleep/wake cycle, sleep| |nitric oxide mediated signal transduction| |regulation of circadian sleep/wake cycle| |negative regulation of cAMP-mediated signaling| |negative regulation of nervous system process| |positive regulation of behavior| |regulation of feeding behavior| |behavioral fear response| |positive regulation of response to drug| |behavioral defense response| |positive regulation of smooth muscle contraction| |non-motile cilium| |fear response| |positive regulation of amine transport| |calcium channel regulator activity| |regulation of sensory perception of pain| |modulation of excitatory postsynaptic potential| |regulation of dopamine secretion| |regulation of sensory perception| |positive regulation of muscle contraction| |regulation of cAMP-mediated signaling| |regulation of smooth muscle contraction| |negative regulation of synaptic transmission| |regulation of catecholamine secretion| |multicellular organismal response to stress| |regulation of synaptic transmission, glutamatergic| |regulation of behavior| |cardiac ventricle morphogenesis| |outflow tract morphogenesis| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |regulation of amine transport| |regulation of response to drug| |neuropeptide signaling pathway| |regulation of circadian rhythm| |positive regulation of cell-substrate adhesion| |cardiac chamber morphogenesis| |cardiac ventricle development| |regulation of nervous system process| |regulation of muscle contraction| |cardiac chamber development| |locomotory behavior| |cilium| |signaling receptor activity| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |regulation of cell-substrate adhesion| |negative regulation of secretion| |regulation of muscle system process| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |heart morphogenesis| |positive regulation of ion transport| |aging| |positive regulation of cytosolic calcium ion concentration| |positive regulation of peptide secretion| |regulation of cytosolic calcium ion concentration| |second-messenger-mediated signaling| |positive regulation of secretion by cell| |positive regulation of cell adhesion| |regulation of membrane potential| |positive regulation of secretion| |cellular calcium ion homeostasis| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |negative regulation of transport| |divalent inorganic cation homeostasis| |regulation of peptide secretion| |negative regulation of intracellular signal transduction| |heart development| |cellular metal ion homeostasis| |behavior| |regulation of system process| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |regulation of cell adhesion| |regulation of ion transport| |cation homeostasis| |inorganic ion homeostasis| |regulation of peptide transport| |cellular chemical homeostasis| |regulation of secretion by cell| |ion homeostasis| |regulation of secretion| |circulatory system development| |cellular homeostasis| |animal organ morphogenesis| |positive regulation of transport| |chemical homeostasis| |secretion| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |G protein-coupled receptor signaling pathway| |defense response| |negative regulation of cell communication| |negative regulation of signaling| |integral component of plasma membrane| |negative regulation of response to stimulus| |homeostatic process| |intracellular signal transduction| |positive regulation of multicellular organismal process| |regulation of intracellular signal transduction| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.96| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12136 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}